Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 3 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
June 2, 2022 ELVN A 8,500 · · 8,500 Direct · Acquired (price as of 2026-10-05)
June 29, 2021 ELVN A 7,728 · · 7,728 Direct · Acquired (price as of 2026-10-05)
April 22, 2020 ELVN A 15,457 · · 15,457 Direct · Acquired (price as of 2026-10-05)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
June 2, 2022 ELVN Stock Options (Right to Buy) Common Stock (8,500) $1.07 June 1, 2032 8,500 Acquired
June 29, 2021 ELVN Stock Options (Right to Buy) Common Stock (7,728) $8.12 June 28, 2031 7,728 Acquired
April 22, 2020 ELVN Stock Option (right to buy) Common Stock (15,457) $16.00 April 21, 2030 15,457 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 2 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
Oct. 17, 2025 ARDX Common Stock · Direct
Oct. 17, 2025 ARDX Stock Option (Right to Buy)→ Common Stock (463,268) 463,268 Direct

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

ARDX

M.D.(6)Former Chief Medical Officer
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2025 $213,019 · $1,574,775 $1,836,116 · · · $3,623,910

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.